RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Randomized, double‐blind, placebo‐controlled trial of the once‐daily GLP‐1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently …

Randomized, double‐blind, placebo‐controlled trial of the once‐daily GLP‐1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently …

Add to Collection
RCTs Y Seino, KW Min, E Niemoeller… - Diabetes, Obesity …, 2012 - Wiley Online Library

Chapter : Section7
Journal Year : 2012
Cited by : 298

… Optimal drug therapy may also be limited by side effects, … in post-meal glucose levels and suppression of postprandial … (the remainder were of Chinese or Indian origin), looked at …..... Read More

Keywords : ['randomize doubleblind placebocontrolle trial', 'oncedaily receptor agonist lixisenatide', 'type diabetes insufficiently', 'asian patient']
PubMed Link : https://dom-pubs.onlinelibrary.wiley.com/doi/abs/10.1111/j.1463-1326.2012.01618.x
Google Scholar Link : https://scholar.google.com/scholar?cites=14652161996300494150&as_sdt=2005&sciodt=0,5&hl=en&num=20